A 52-year-old man with obesity (BMI 32 kg/m²) is newly diagnosed with type 2 diabetes mellitus after fasting glucose 8.0 mmol/L and HbA1c 57 mmol/mol (7.4%). He has no symptoms and no significant comorbidities. According to Australian primary care guidelines, what is the most appropriate initial pharmacological management in addition to lifestyle interventions?